Concepedia

Reynaldo Garcia

RG

5

Publications

428

Citations

5

H-Index

2004

Active since

Affiliations

University of North Carolina at Chapel Hill(Current)

Reynaldo Garcia is an author at University of North Carolina at Chapel Hill specializing in health sciences, pathology, and radiation oncology.

Top concepts

Publications per year

2004–2011

5

Publications

5

Phase 1 trial of the proteasome inhibitor bortezomib and pegylated liposomal doxorubicin in patients with advanced hematologic malignancies

Robert Z. Orlowski, Peter M. Voorhees, Reynaldo Garcia et al. · Blood · 2004 · 319 citations

Extended follow-up of outcome measures in multiple myeloma patients treated on a phase I study with bortezomib and pegylated liposomal doxorubicin

Suzanne E. Biehn, Dominic T. Moore, Peter M. Voorhees et al. · Annals of Hematology · 2006 · 46 citations

, , +8

Phase II Study of Capecitabine, Oxaliplatin, and Cetuximab for Advanced Hepatocellular Carcinoma.

Hanna K. Sanoff, Stephen A. Bernard, Richard M. Goldberg et al. · PubMed · 2011 · 42 citations · Full text

Vorinostat in Combination with Pegylated Liposomal Doxorubicin and Bortezomib for Patients with Relapsed/Refractory Multiple Myeloma: Results of a Phase I Study.

Peter M. Voorhees, Cristina Gasparetto, Kristy L. Richards et al. · Blood · 2009 · 11 citations

Phase I Study of the Novel Surivin and cdc2/CDK1 Inhibitor Terameprocol in Patients with Advanced Leukemias.

Raoul Tibes, Kevin T. McDonagh, Lazaros J. Lekakis et al. · Blood · 2009 · 10 citations

Rows per page

1–5 of 5